Selected research
Market Outlook & Growth Opportunities
Global Medical Device Testing and Validation Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Medical Device Testing and Validation Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Medical Device Testing and Validation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Device Testing and Validation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Device Testing and Validation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Medical Device Testing and Validation Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Medical Device Testing and Validation Service market include SGS, TÜV SÜD AG, Intertek Group plc, Element Materials Technology, Bureau Veritas, Pace Analytical Services, Wuxi Apptec, NAMSA and Nelson Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Medical Device Testing and Validation Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Device Testing and Validation Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Device Testing and Validation Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Device Testing and Validation Service market.
Medical Device Testing and Validation Service Segment by Company
SGS
TÜV SÜD AG
Intertek Group plc
Element Materials Technology
Bureau Veritas
Pace Analytical Services
Wuxi Apptec
NAMSA
Nelson Laboratories
Eurofins Scientific
Charles River Laboratories
QuEST Global Services
Medical Device Testing and Validation Service Segment by Type
Biocompatibility Testing Service
Electrical and Mechanical Testing Service
Sterility and Microbiology Testing Service
Others
Medical Device Testing and Validation Service Segment by Application
Regulatory Compliance Testing
Product Safety and Performance Validation
Quality Assurance and Certification
Clinical Evaluation and Trials Support
Packaging and Sterilization Validation
Others
Medical Device Testing and Validation Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Medical Device Testing and Validation Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Medical Device Testing and Validation Service key companies, revenue, market share, and recent developments.
3. To split the Medical Device Testing and Validation Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Medical Device Testing and Validation Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Medical Device Testing and Validation Service significant trends, drivers, influence factors in global and regions.
6. To analyze Medical Device Testing and Validation Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Device Testing and Validation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Device Testing and Validation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Device Testing and Validation Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Device Testing and Validation Service industry.
Chapter 3: Detailed analysis of Medical Device Testing and Validation Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Medical Device Testing and Validation Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Medical Device Testing and Validation Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Medical Device Testing and Validation Service Industry Trends
Table 2. Medical Device Testing and Validation Service Industry Drivers
Table 3. Medical Device Testing and Validation Service Industry Opportunities and Challenges
Table 4. Medical Device Testing and Validation Service Industry Restraints
Table 5. Global Medical Device Testing and Validation Service Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Medical Device Testing and Validation Service Revenue Share by Company (2021-2026)
Table 7. Global Medical Device Testing and Validation Service Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Medical Device Testing and Validation Service Key Company Manufacturing Base & Headquarters
Table 9. Global Medical Device Testing and Validation Service Company, Product Type & Application
Table 10. Global Medical Device Testing and Validation Service Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Medical Device Testing and Validation Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Biocompatibility Testing Service
Table 15. Significant Companies of Electrical and Mechanical Testing Service
Table 16. Significant Companies of Sterility and Microbiology Testing Service
Table 17. Significant Companies of Others
Table 18. Global Medical Device Testing and Validation Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 19. Global Medical Device Testing and Validation Service Sales Value by Type (2021-2026) & (US$ Million)
Table 20. Global Medical Device Testing and Validation Service Sales Value by Type (2027-2032) & (US$ Million)
Table 21. Global Medical Device Testing and Validation Service Sales Value Share by Type (2021-2026)
Table 22. Global Medical Device Testing and Validation Service Sales Value Share by Type (2027-2032)
Table 23. Significant Companies of Regulatory Compliance Testing
Table 24. Significant Companies of Product Safety and Performance Validation
Table 25. Significant Companies of Quality Assurance and Certification
Table 26. Significant Companies of Clinical Evaluation and Trials Support
Table 27. Significant Companies of Packaging and Sterilization Validation
Table 28. Significant Companies of Others
Table 29. Global Medical Device Testing and Validation Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 30. Global Medical Device Testing and Validation Service Sales Value by Application (2021-2026) & (US$ Million)
Table 31. Global Medical Device Testing and Validation Service Sales Value by Application (2027-2032) & (US$ Million)
Table 32. Global Medical Device Testing and Validation Service Sales Value Share by Application (2021-2026)
Table 33. Global Medical Device Testing and Validation Service Sales Value Share by Application (2027-2032)
Table 34. Global Medical Device Testing and Validation Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 35. Global Medical Device Testing and Validation Service Sales Value by Region (2021-2026) & (US$ Million)
Table 36. Global Medical Device Testing and Validation Service Sales Value Share by Region (2021-2026)
Table 37. Global Medical Device Testing and Validation Service Sales Value by Region (2027-2032) & (US$ Million)
Table 38. Global Medical Device Testing and Validation Service Sales Value Share by Region (2027-2032)
Table 39. Global Medical Device Testing and Validation Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. Global Medical Device Testing and Validation Service Sales Value by Country (2021-2026) & (US$ Million)
Table 41. Global Medical Device Testing and Validation Service Sales Value Market Share by Country (2021-2026)
Table 42. Global Medical Device Testing and Validation Service Sales Value by Country (2027-2032) & (US$ Million)
Table 43. Global Medical Device Testing and Validation Service Sales Value Market Share by Country (2027-2032)
Table 44. SGS Company Information
Table 45. SGS Business Overview
Table 46. SGS Medical Device Testing and Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. SGS Medical Device Testing and Validation Service Product Portfolio
Table 48. SGS Recent Development
Table 49. TÜV SÜD AG Company Information
Table 50. TÜV SÜD AG Business Overview
Table 51. TÜV SÜD AG Medical Device Testing and Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 52. TÜV SÜD AG Medical Device Testing and Validation Service Product Portfolio
Table 53. TÜV SÜD AG Recent Development
Table 54. Intertek Group plc Company Information
Table 55. Intertek Group plc Business Overview
Table 56. Intertek Group plc Medical Device Testing and Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 57. Intertek Group plc Medical Device Testing and Validation Service Product Portfolio
Table 58. Intertek Group plc Recent Development
Table 59. Element Materials Technology Company Information
Table 60. Element Materials Technology Business Overview
Table 61. Element Materials Technology Medical Device Testing and Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 62. Element Materials Technology Medical Device Testing and Validation Service Product Portfolio
Table 63. Element Materials Technology Recent Development
Table 64. Bureau Veritas Company Information
Table 65. Bureau Veritas Business Overview
Table 66. Bureau Veritas Medical Device Testing and Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 67. Bureau Veritas Medical Device Testing and Validation Service Product Portfolio
Table 68. Bureau Veritas Recent Development
Table 69. Pace Analytical Services Company Information
Table 70. Pace Analytical Services Business Overview
Table 71. Pace Analytical Services Medical Device Testing and Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 72. Pace Analytical Services Medical Device Testing and Validation Service Product Portfolio
Table 73. Pace Analytical Services Recent Development
Table 74. Wuxi Apptec Company Information
Table 75. Wuxi Apptec Business Overview
Table 76. Wuxi Apptec Medical Device Testing and Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 77. Wuxi Apptec Medical Device Testing and Validation Service Product Portfolio
Table 78. Wuxi Apptec Recent Development
Table 79. NAMSA Company Information
Table 80. NAMSA Business Overview
Table 81. NAMSA Medical Device Testing and Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 82. NAMSA Medical Device Testing and Validation Service Product Portfolio
Table 83. NAMSA Recent Development
Table 84. Nelson Laboratories Company Information
Table 85. Nelson Laboratories Business Overview
Table 86. Nelson Laboratories Medical Device Testing and Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 87. Nelson Laboratories Medical Device Testing and Validation Service Product Portfolio
Table 88. Nelson Laboratories Recent Development
Table 89. Eurofins Scientific Company Information
Table 90. Eurofins Scientific Business Overview
Table 91. Eurofins Scientific Medical Device Testing and Validation Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 92. Eurofins Scientific Medical Device Testing and Validation Service Product Portfolio
Table 93. Eurofins Scientific Recent Development
Table 94. Charles River Laboratories Company Information
Table 95. Charles River Laboratories Business Overview
Table 96. Charles River Laboratories Medical Device Testing and Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 97. Charles River Laboratories Medical Device Testing and Validation Service Product Portfolio
Table 98. Charles River Laboratories Recent Development
Table 99. QuEST Global Services Company Information
Table 100. QuEST Global Services Business Overview
Table 101. QuEST Global Services Medical Device Testing and Validation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 102. QuEST Global Services Medical Device Testing and Validation Service Product Portfolio
Table 103. QuEST Global Services Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Authors List of This Report
Table 106. Secondary Sources
Table 107. Primary Sources
List of Figures
Figure 1. Medical Device Testing and Validation Service Product Image
Figure 2. Global Medical Device Testing and Validation Service Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Medical Device Testing and Validation Service Market Size (2021-2032) & (US$ Million)
Figure 4. Global Medical Device Testing and Validation Service Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Biocompatibility Testing Service Image
Figure 8. Electrical and Mechanical Testing Service Image
Figure 9. Sterility and Microbiology Testing Service Image
Figure 10. Others Image
Figure 11. Global Medical Device Testing and Validation Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 12. Global Medical Device Testing and Validation Service Sales Value Share 2021 VS 2025 VS 2032
Figure 13. Global Medical Device Testing and Validation Service Sales Value Share by Type (2021-2032)
Figure 14. Regulatory Compliance Testing Image
Figure 15. Product Safety and Performance Validation Image
Figure 16. Quality Assurance and Certification Image
Figure 17. Clinical Evaluation and Trials Support Image
Figure 18. Packaging and Sterilization Validation Image
Figure 19. Others Image
Figure 20. Global Medical Device Testing and Validation Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 21. Global Medical Device Testing and Validation Service Sales Value Share 2021 VS 2025 VS 2032
Figure 22. Global Medical Device Testing and Validation Service Sales Value Share by Application (2021-2032)
Figure 23. Global Medical Device Testing and Validation Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 24. Global Medical Device Testing and Validation Service Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 25. North America Medical Device Testing and Validation Service Sales Value (2021-2032) & (US$ Million)
Figure 26. North America Medical Device Testing and Validation Service Sales Value Share by Country (%), 2025 VS 2032
Figure 27. Europe Medical Device Testing and Validation Service Sales Value (2021-2032) & (US$ Million)
Figure 28. Europe Medical Device Testing and Validation Service Sales Value Share by Country (%), 2025 VS 2032
Figure 29. Asia-Pacific Medical Device Testing and Validation Service Sales Value (2021-2032) & (US$ Million)
Figure 30. Asia-Pacific Medical Device Testing and Validation Service Sales Value Share by Country (%), 2025 VS 2032
Figure 31. South America Medical Device Testing and Validation Service Sales Value (2021-2032) & (US$ Million)
Figure 32. South America Medical Device Testing and Validation Service Sales Value Share by Country (%), 2025 VS 2032
Figure 33. Middle East & Africa Medical Device Testing and Validation Service Sales Value (2021-2032) & (US$ Million)
Figure 34. Middle East & Africa Medical Device Testing and Validation Service Sales Value Share by Country (%), 2025 VS 2032
Figure 35. USA Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 36. USA Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 37. USA Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 38. Canada Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 39. Canada Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 40. Canada Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 41. Mexico Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 42. Mexico Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 43. Mexico Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 44. Germany Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 45. Germany Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 46. Germany Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 47. France Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 48. France Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 49. France Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 50. U.K. Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 51. U.K. Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 52. U.K. Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 53. Italy Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 54. Italy Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 55. Italy Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 56. Spain Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 57. Spain Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 58. Spain Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 59. Russia Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 60. Russia Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 61. Russia Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 62. Netherlands Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 63. Netherlands Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 64. Netherlands Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 65. Nordic Countries Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 66. Nordic Countries Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 67. Nordic Countries Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 68. China Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 69. China Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 70. China Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 71. Japan Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 72. Japan Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 73. Japan Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 74. South Korea Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 75. South Korea Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 76. South Korea Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 77. India Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 78. India Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 79. India Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 80. Australia Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 81. Australia Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 82. Australia Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 83. Southeast Asia Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 84. Southeast Asia Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 85. Southeast Asia Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 86. Brazil Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 87. Brazil Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 88. Brazil Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 89. Argentina Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 90. Argentina Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 91. Argentina Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 92. Chile Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 93. Chile Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 94. Chile Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 95. Colombia Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 96. Colombia Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 97. Colombia Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 98. Peru Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 99. Peru Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 100. Peru Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 101. Saudi Arabia Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 102. Saudi Arabia Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 103. Saudi Arabia Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 104. Israel Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 105. Israel Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 106. Israel Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 107. UAE Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 108. UAE Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 109. UAE Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 110. Turkey Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 111. Turkey Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 112. Turkey Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 113. Iran Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 114. Iran Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 115. Iran Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 116. Egypt Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 117. Egypt Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 118. Egypt Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 119. Years Considered
Figure 120. Research Process
Figure 121. Key Executives Interviewed
Scope & coverage.
Types
- Biocompatibility Testing Service
- Electrical and Mechanical Testing Service
- Sterility and Microbiology Testing Service
- Others
Applications
- Regulatory Compliance Testing
- Product Safety and Performance Validation
- Quality Assurance and Certification
- Clinical Evaluation and Trials Support
- Packaging and Sterilization Validation
- Others
Companies covered
- SGS
- TÜV SÜD AG
- Intertek Group plc
- Element Materials Technology
- Bureau Veritas
- Pace Analytical Services
- Wuxi Apptec
- NAMSA
- Nelson Laboratories
- Eurofins Scientific
- Charles River Laboratories
- QuEST Global Services
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Medical Device Testing and Validation Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Medical Device Testing and Validation Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Medical Device Testing and Validation Service Market Dynamics
- 2.1 Medical Device Testing and Validation Service Industry Trends
- 2.2 Medical Device Testing and Validation Service Industry Drivers
- 2.3 Medical Device Testing and Validation Service Industry Opportunities and Challenges
- 2.4 Medical Device Testing and Validation Service Industry Restraints
3 Medical Device Testing and Validation Service Market by Company
- 3.1 Global Medical Device Testing and Validation Service Company Revenue Ranking in 2025
- 3.2 Global Medical Device Testing and Validation Service Revenue by Company (2021-2026)
- 3.3 Global Medical Device Testing and Validation Service Company Ranking (2024-2026)
- 3.4 Global Medical Device Testing and Validation Service Company Manufacturing Base and Headquarters
- 3.5 Global Medical Device Testing and Validation Service Company Product Type and Application
- 3.6 Global Medical Device Testing and Validation Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Medical Device Testing and Validation Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Medical Device Testing and Validation Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Medical Device Testing and Validation Service Market by Type
- 4.1 Medical Device Testing and Validation Service Type Introduction
- 4.1.1 Biocompatibility Testing Service
- 4.1.2 Electrical and Mechanical Testing Service
- 4.1.3 Sterility and Microbiology Testing Service
- 4.1.4 Others
- 4.2 Global Medical Device Testing and Validation Service Sales Value by Type
- 4.2.1 Global Medical Device Testing and Validation Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical Device Testing and Validation Service Sales Value by Type (2021-2032)
- 4.2.3 Global Medical Device Testing and Validation Service Sales Value Share by Type (2021-2032)
5 Medical Device Testing and Validation Service Market by Application
- 5.1 Medical Device Testing and Validation Service Application Introduction
- 5.1.1 Regulatory Compliance Testing
- 5.1.2 Product Safety and Performance Validation
- 5.1.3 Quality Assurance and Certification
- 5.1.4 Clinical Evaluation and Trials Support
- 5.1.5 Packaging and Sterilization Validation
- 5.1.6 Others
- 5.2 Global Medical Device Testing and Validation Service Sales Value by Application
- 5.2.1 Global Medical Device Testing and Validation Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical Device Testing and Validation Service Sales Value by Application (2021-2032)
- 5.2.3 Global Medical Device Testing and Validation Service Sales Value Share by Application (2021-2032)
6 Medical Device Testing and Validation Service Regional Value Analysis
- 6.1 Global Medical Device Testing and Validation Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medical Device Testing and Validation Service Sales Value by Region (2021-2032)
- 6.2.1 Global Medical Device Testing and Validation Service Sales Value by Region: 2021-2026
- 6.2.2 Global Medical Device Testing and Validation Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medical Device Testing and Validation Service Sales Value (2021-2032)
- 6.3.2 North America Medical Device Testing and Validation Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Medical Device Testing and Validation Service Sales Value (2021-2032)
- 6.4.2 Europe Medical Device Testing and Validation Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Medical Device Testing and Validation Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Medical Device Testing and Validation Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Medical Device Testing and Validation Service Sales Value (2021-2032)
- 6.6.2 South America Medical Device Testing and Validation Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Medical Device Testing and Validation Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Medical Device Testing and Validation Service Sales Value Share by Country, 2025 VS 2032
7 Medical Device Testing and Validation Service Country-level Value Analysis
- 7.1 Global Medical Device Testing and Validation Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Medical Device Testing and Validation Service Sales Value by Country (2021-2032)
- 7.2.1 Global Medical Device Testing and Validation Service Sales Value by Country (2021-2026)
- 7.2.2 Global Medical Device Testing and Validation Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Medical Device Testing and Validation Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Medical Device Testing and Validation Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Medical Device Testing and Validation Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 SGS
- 8.1.1 SGS Company Information
- 8.1.2 SGS Business Overview
- 8.1.3 SGS Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 8.1.4 SGS Medical Device Testing and Validation Service Product Portfolio
- 8.1.5 SGS Recent Developments
- 8.2 TÜV SÜD AG
- 8.2.1 TÜV SÜD AG Company Information
- 8.2.2 TÜV SÜD AG Business Overview
- 8.2.3 TÜV SÜD AG Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 8.2.4 TÜV SÜD AG Medical Device Testing and Validation Service Product Portfolio
- 8.2.5 TÜV SÜD AG Recent Developments
- 8.3 Intertek Group plc
- 8.3.1 Intertek Group plc Company Information
- 8.3.2 Intertek Group plc Business Overview
- 8.3.3 Intertek Group plc Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Intertek Group plc Medical Device Testing and Validation Service Product Portfolio
- 8.3.5 Intertek Group plc Recent Developments
- 8.4 Element Materials Technology
- 8.4.1 Element Materials Technology Company Information
- 8.4.2 Element Materials Technology Business Overview
- 8.4.3 Element Materials Technology Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Element Materials Technology Medical Device Testing and Validation Service Product Portfolio
- 8.4.5 Element Materials Technology Recent Developments
- 8.5 Bureau Veritas
- 8.5.1 Bureau Veritas Company Information
- 8.5.2 Bureau Veritas Business Overview
- 8.5.3 Bureau Veritas Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Bureau Veritas Medical Device Testing and Validation Service Product Portfolio
- 8.5.5 Bureau Veritas Recent Developments
- 8.6 Pace Analytical Services
- 8.6.1 Pace Analytical Services Company Information
- 8.6.2 Pace Analytical Services Business Overview
- 8.6.3 Pace Analytical Services Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Pace Analytical Services Medical Device Testing and Validation Service Product Portfolio
- 8.6.5 Pace Analytical Services Recent Developments
- 8.7 Wuxi Apptec
- 8.7.1 Wuxi Apptec Company Information
- 8.7.2 Wuxi Apptec Business Overview
- 8.7.3 Wuxi Apptec Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Wuxi Apptec Medical Device Testing and Validation Service Product Portfolio
- 8.7.5 Wuxi Apptec Recent Developments
- 8.8 NAMSA
- 8.8.1 NAMSA Company Information
- 8.8.2 NAMSA Business Overview
- 8.8.3 NAMSA Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 8.8.4 NAMSA Medical Device Testing and Validation Service Product Portfolio
- 8.8.5 NAMSA Recent Developments
- 8.9 Nelson Laboratories
- 8.9.1 Nelson Laboratories Company Information
- 8.9.2 Nelson Laboratories Business Overview
- 8.9.3 Nelson Laboratories Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Nelson Laboratories Medical Device Testing and Validation Service Product Portfolio
- 8.9.5 Nelson Laboratories Recent Developments
- 8.10 Eurofins Scientific
- 8.10.1 Eurofins Scientific Company Information
- 8.10.2 Eurofins Scientific Business Overview
- 8.10.3 Eurofins Scientific Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Eurofins Scientific Medical Device Testing and Validation Service Product Portfolio
- 8.10.5 Eurofins Scientific Recent Developments
- 8.11 Charles River Laboratories
- 8.11.1 Charles River Laboratories Company Information
- 8.11.2 Charles River Laboratories Business Overview
- 8.11.3 Charles River Laboratories Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Charles River Laboratories Medical Device Testing and Validation Service Product Portfolio
- 8.11.5 Charles River Laboratories Recent Developments
- 8.12 QuEST Global Services
- 8.12.1 QuEST Global Services Company Information
- 8.12.2 QuEST Global Services Business Overview
- 8.12.3 QuEST Global Services Medical Device Testing and Validation Service Revenue and Gross Margin (2021-2026)
- 8.12.4 QuEST Global Services Medical Device Testing and Validation Service Product Portfolio
- 8.12.5 QuEST Global Services Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst